Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Slowing Down Stock
944.1000 -14.30 (-1.49%)
NSE Aug 14, 2025 15:52 PM
Volume: 60,684
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
944.10
-1.49%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences.. has an average target of 1317.00 from 1 broker.
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - August 14, 2025
The Baseline | 14 Aug 2025, 04:39PM
Market closes flat, Amara Raja's Q1 net profit drops 20.7% YoY to Rs 194 crore
Trendlyne Marketwatch | 14 Aug 2025, 03:56PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021